scPharmaceuticals Inc (NASDAQ: SCPH) on Friday, plunged -7.58% from the previous trading day, before settling in for the closing price of $5.01. Within the past 52 weeks, SCPH’s price has moved between $1.94 and $6.28.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
Over the past five-year period, the drop rate of yearbook sales for the company of the Healthcare sector was -1.52%. The company achieved an average annual earnings per share of 42.20%. With a float of $36.17 million, this company’s outstanding shares have now reached $53.29 million.
Considering the fact that the conglomerate employs 164 people, you should pay attention to its efficiency factor. In terms of profitability, gross margin is 68.92%, operating margin of -158.82%, and the pretax margin is -216.24%.
scPharmaceuticals Inc (SCPH) Insider Activity
Observing investor behavior towards Biotechnology industry stocks is more important than anything else. The insider ownership of scPharmaceuticals Inc is 32.13%, while institutional ownership is 56.68%. The most recent insider transaction that took place on Aug 13 ’24, was worth 2,000,000. In this transaction 10% Owner of this company bought 500,000 shares at a rate of $4.00, taking the stock ownership to the 5,806,670 shares.
scPharmaceuticals Inc (SCPH) Earnings and Forecasts
As on 9/30/2024, Multinational firm has announced its last quarter scores, in which it reported -0.37 earnings per share (EPS) for the period falling under the consensus outlook (set at -0.3) by -0.07. Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.16 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 42.20% per share during the next fiscal year.
scPharmaceuticals Inc (NASDAQ: SCPH) Trading Performance Indicators
scPharmaceuticals Inc (SCPH) is currently performing well based on its current performance indicators. A quick ratio of 3.14 was reported for the most recent quarter. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 4.94.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -1.81, a number that is poised to hit -0.24 in the next quarter and is forecasted to reach -0.22 in one year’s time.
Technical Analysis of scPharmaceuticals Inc (SCPH)
Compared to the last year’s volume of 0.38 million, its volume of 0.36 million showed lagged in the last five days. As of the previous 9 days, the stock’s Stochastic %D was 24.24%.
During the past 100 days, scPharmaceuticals Inc’s (SCPH) raw stochastic average was set at 61.98%, which indicates a significant increase from 23.17% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 0.39 in the past 14 days, which was higher than the 0.25 volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $4.45, while its 200-day Moving Average is $3.55.
